Robert I. Roth

1.2k total citations
37 papers, 952 citations indexed

About

Robert I. Roth is a scholar working on Immunology, Cell Biology and Molecular Biology. According to data from OpenAlex, Robert I. Roth has authored 37 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Cell Biology and 8 papers in Molecular Biology. Recurrent topics in Robert I. Roth's work include Hemoglobin structure and function (12 papers), Immune Response and Inflammation (11 papers) and Antimicrobial Peptides and Activities (3 papers). Robert I. Roth is often cited by papers focused on Hemoglobin structure and function (12 papers), Immune Response and Inflammation (11 papers) and Antimicrobial Peptides and Activities (3 papers). Robert I. Roth collaborates with scholars based in United States, Poland and Japan. Robert I. Roth's co-authors include J Levin, Wiesław Kaca, Jack Levin, Antonio M. Gotto, David F. Keren, Robert L. Owen, Paul A. Volberding, John W. Gaubatz, Motonobu Yoshida and Richard L. Jackson and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Robert I. Roth

35 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert I. Roth United States 18 291 280 180 168 157 37 952
Manuel Conde Spain 18 202 0.7× 430 1.5× 286 1.6× 52 0.3× 86 0.5× 49 1.3k
Liliana Håversen Sweden 14 205 0.7× 297 1.1× 242 1.3× 56 0.3× 150 1.0× 29 1.0k
J Hakim France 21 603 2.1× 406 1.4× 217 1.2× 36 0.2× 97 0.6× 70 1.5k
L Róka Germany 16 137 0.5× 320 1.1× 84 0.5× 48 0.3× 87 0.6× 56 990
Axel Ring Germany 15 130 0.4× 586 2.1× 418 2.3× 234 1.4× 235 1.5× 17 1.4k
Rita M. Heuertz United States 14 274 0.9× 289 1.0× 217 1.2× 73 0.4× 59 0.4× 35 855
Paul W. Tebbey United States 18 356 1.2× 370 1.3× 244 1.4× 25 0.1× 78 0.5× 31 1.0k
Lee E. Bartholomew United States 12 155 0.5× 178 0.6× 135 0.8× 37 0.2× 274 1.7× 16 1.2k
I.S. Levij Israel 14 114 0.4× 195 0.7× 129 0.7× 69 0.4× 114 0.7× 38 761
H Lührs Germany 19 197 0.7× 878 3.1× 112 0.6× 56 0.3× 247 1.6× 27 1.6k

Countries citing papers authored by Robert I. Roth

Since Specialization
Citations

This map shows the geographic impact of Robert I. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Roth more than expected).

Fields of papers citing papers by Robert I. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Roth. The network helps show where Robert I. Roth may publish in the future.

Co-authorship network of co-authors of Robert I. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Roth. A scholar is included among the top collaborators of Robert I. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Roth. Robert I. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Robert I. & Nicholas M. Fleischer. (2002). Gene Therapy: Applications to Pharmacy Practice. Journal of the American Pharmaceutical Association (1996). 42(5). 692–698. 5 indexed citations
2.
Roth, Robert I.. (2001). Magic Bullets Finally Find Their Mark. Journal of the American Pharmaceutical Association (1996). 41(3). 383–391.
3.
Roth, Robert I., et al.. (1999). Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. Critical Care Medicine. 27(4). 771–778. 39 indexed citations
4.
Roth, Robert I., et al.. (1998). LimulusAntilipopolysaccharide Factor Prevents Mortality Late in the Course of Endotoxemia. The Journal of Infectious Diseases. 177(2). 388–394. 29 indexed citations
5.
Roth, Robert I., et al.. (1997). Pharmacokinetics, biological effects, and distribution of (1→3)‐β‐D‐glucan in blood and organs in rabbits. Mediators of Inflammation. 6(4). 279–283. 9 indexed citations
6.
Roth, Robert I., et al.. (1997). Hemoglobin increases mortality from bacterial endotoxin. Infection and Immunity. 65(4). 1258–1266. 64 indexed citations
7.
Roth, Robert I., et al.. (1996). Soluble (1→3)-β-D-glucan purified from Candida albicans: Biologic effects and distribution in blood and organs in rabbits. Journal of Laboratory and Clinical Medicine. 128(1). 103–114. 29 indexed citations
8.
Gelb, Arnold B., Robert I. Roth, Jack Levin, et al.. (1996). Changes in Blood Coagulation During and Following Cardiopulmonary Bypass:Lack of Correlation With Clinical Bleeding. American Journal of Clinical Pathology. 106(1). 87–99. 80 indexed citations
9.
Roth, Robert I.. (1996). Hemoglobin Enhances the Binding of Bacterial Endotoxin to Human Endothelial Cells. Thrombosis and Haemostasis. 76(2). 258–262. 19 indexed citations
10.
Kaca, Wiesław, Robert I. Roth, Kim D. Vandegriff, et al.. (1995). Effects of Bacterial Endotoxin on Human Cross-Linked and Native Hemoglobins. Biochemistry. 34(35). 11176–11185. 42 indexed citations
11.
Kaca, Wiesław & Robert I. Roth. (1995). Activation of complement by human hemoglobin and by mixtures of hemoglobin and bacterial endotoxin. Biochimica et Biophysica Acta (BBA) - General Subjects. 1245(1). 49–56. 15 indexed citations
12.
Roth, Robert I., Wiesław Kaca, & Judith G. Levin. (1994). Hemoglobin: a newly recognized binding protein for bacterial endotoxins (LPS).. PubMed. 388. 161–72. 15 indexed citations
13.
Roth, Robert I. & J Levin. (1994). [6] Measurement of endotoxin levels in hemoglobin preparations. Methods in enzymology on CD-ROM/Methods in enzymology. 231. 75–91. 4 indexed citations
14.
Roth, Robert I. & Wiesław Kaca. (1994). Toxicity of Hemoglobin Solutions: Hemoglobin is a Lipopolysaccharide (Lps) Binding Protein which Enhances Lps Biological Activity. Artificial Cells Blood Substitutes and Biotechnology. 22(3). 387–398. 7 indexed citations
15.
Kaca, Wiesław, Robert I. Roth, Andrzej Ziółkowski, & J Levin. (1994). Human hemoglobin increases the biological activity of bacterial lipopolysaccharides in activation of Limulus amebocyte lysate and stimulation of tissue factor production by endothelial cells in vitro. Journal of Endotoxin Research. 1(4). 243–252. 21 indexed citations
16.
17.
Roth, Robert I., et al.. (1989). Stability of gels formed following coagulation of limulus amebocyte lysate: Lack of covalent crosslinking of coagulin. Thrombosis Research. 55(1). 25–36. 7 indexed citations
18.
Roth, Robert I. & Jack Levin. (1989). Amplification of chromogenic staining of proteases within electrophoretic gels. Journal of Biochemical and Biophysical Methods. 19(2-3). 129–141. 4 indexed citations
19.
Roth, Robert I., et al.. (1983). Effect of cholesterol feeding on the distribution of plasma lipoproteins and on the metabolism of apolipoprotein E in the rabbit. Journal of Lipid Research. 24(1). 1–11. 66 indexed citations
20.
Pownall, Henry J., Richard L. Jackson, Robert I. Roth, et al.. (1980). Influence of an atherogenic diet on the structure of swine low density lipoproteins. Journal of Lipid Research. 21(8). 1108–1115. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Conde Breakdown of academic impact, for papers by Liliana Håversen Breakdown of academic impact, for papers by J Hakim Breakdown of academic impact, for papers by L Róka Breakdown of academic impact, for papers by Axel Ring Breakdown of academic impact, for papers by Rita M. Heuertz Breakdown of academic impact, for papers by Paul W. Tebbey Breakdown of academic impact, for papers by Lee E. Bartholomew Breakdown of academic impact, for papers by I.S. Levij Breakdown of academic impact, for papers by H Lührs
Rankless by CCL
2026